Kestrel Therapeutics
PrivateLast Round
Corporate Funding
Apr 28, 2026
Total Funding Raised
$48M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Kestrel Therapeutics is a biotechnology company that develops small-molecule inhibitors targeting mutant KRAS proteins for the treatment of intractable cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kestrel Therapeutics Comparables
Compare Kestrel Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quanta Therapeutics | 85% | |
| Jacobio Pharmaceuticals Group Co Ltd | 80% | |
| Revolution Medicines | 79% | |
Kestrel Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Apr 28, 2026 | ||||
| VC Round | Aug 12, 2025 | ||||
| Convertible Debt | Feb 21, 2025 | ||||
| Series A | Dec 1, 2021 |
Kestrel Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series A |
| Cormorant Asset Management | Series A |
| Santé Ventures | VC Round, Series A |
| Pfizer | Series A |
| Cormorant Asset Management | Series A |
| Pfizer Ventures | VC Round, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
AbbVie led the corporate funding round.
- Aug 12, 2025
$5M raised from Pfizer Ventures and Santé Ventures.
Kestrel Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kestrel Therapeutics's valuation, stock price, and market status.